new molecules and indications for glp-1 medicines A glimpse of the future: GLP1 agonists 💡💉 GLP-1 Medications: Everything You Need

J Clin Invest 63(2):230238

Future Directions and Emerging Applications The future of GLP-1 receptor agonists (GLP-1RAs) in neurology focuses on multi-receptor agonists, innovative delivery systems, and precision medicine approaches

1 Later, the American Association for the Study of Liver Diseases led the adoption of a new multisociety Delphi consensus in 2023, proposing metabolic dysfunction-associated steatotic liver disease (MASLD) as another replacement term for nonalcoholic fatty liver disease

FXR is a molecular target for the effects of vertical sleeve gastrectomy

This allows it to effectively avoid degradation by lysosomes and greatly extend the half-life

GLP-1 agonists may represent a paradigm shift: metabolic drugs with measurable effects on craving and reward circuitry